New hope for aggressive lung cancer: phase 3 trial launches
NCT ID NCT06712355
First seen Jun 27, 2026 · Last updated Sep 02, 2026 · Updated 5 times
Summary
This study tests whether a new drug called BNT327, combined with standard chemotherapy, helps people with advanced small-cell lung cancer live longer compared to another approved drug (atezolizumab) plus the same chemo. About 621 adults who have not yet been treated for their cancer will take part. The goal is to see if the new combination improves survival and slows tumor growth.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 621 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2025
- Expected to finish
-
Mar 2029
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Have histologically or cytologically confirmed ES-SCLC (using the AJCC \[American Joint Committee on Cancer\] tumor node metastasis staging system combined with Veterans Administration Lung Study Group \[VALG\]'s two stage classification scheme). For AJCC tumor node metastasis staging system: AJCC 8th edition stage IV (T any, N any, M1a/b/c), or T3\~4 for multiple lung nodules or tumor/nodule volume that cannot be encompassed in a tolerable radiotherapy plan. * Have not had prior systemic therapy for ES-SCLC. However, participants with prior chemoradiotherapy for limited-stage-SCLC must have been treated with curative intent and had a treatment-free interval of at least 6 months after the last chemotherapy, radiotherapy, or chemoradiotherapy before diagnosis of ES-SCLC to be eligible. * Have at least one measurable lesion as the targeted lesion based on RECIST v1.1. Lesions treated after prior local treatment (radiotherapy, ablation, interventional procedures, etc.) are generally not considered as target lesions. If the lesion with prior local treatment is the only targeted lesion, evidence-based radiology must be provided to demonstrate disease progression (the single bone metastasis or the single central nervous system metastasis should not be considered as a measurable lesion). * Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. * Adequate hematologic and organ function as defined in the protocol. Exclusion Criteria: * Have histologically or cytologically confirmed SCLC with combined histologies. * Have received any of the following therapies or drugs within the noted time intervals prior to study treatment: * Within 2 weeks: small molecule agents with half-life of \<7 days; radiation outside the thoracic cavity including whole brain radiation. Of note, other local radiation for brain lesions (not whole brain) is allowed; local radiation for bone lesions is allowed. Palliative bone radiation or brain stereotactic radiosurgery would not require a washout period, but participants should recover from radiotherapy-related toxicity. * Within 4 weeks: radiation involving the thoracic cavity; small molecule targeted agents with half-life of ≥7 days; monoclonal antibodies, antibody-drug conjugates, radioimmunoconjugates, or T-cell or other cell-based therapies. * Have received prior treatment with anti-vascular endothelial growth factor (VEGF) monoclonal antibody, or programmed death (ligand)-1 (PD\[L\]-1)/VEGF bispecific antibody. * Have received systemic corticosteroids (at a dosage greater than 10 mg/day of prednisone or an equivalent dose of other corticosteroids) within 7 days prior to the initiation of study treatment. Note: local, intranasal, intraocular, intra-articular or inhaled corticosteroids, short-term use (≤7 days) of corticosteroids for prophylaxis (e.g., prevention of contrast agent allergy) or treatment of non-autoimmune conditions (e.g., delayed hypersensitivity reactions caused by exposure to allergens) are allowed. * Have the following central nervous system metastases: * Participants with untreated brain metastases that are symptomatic or large (e.g., greater than 2 cm). * Participants with treated central nervous system (CNS) metastases who are not neurologically stable or on steroids (at a dosage greater than 10 mg/Day of prednisone or an equivalent dose of other corticosteroid) within 7 days before initiating study treatment of this study. * Participants with known leptomeningeal metastases. * Have uncontrolled hypertension or poorly controlled diabetes prior to study treatment. * Have a serious or non-healing wound, or (incompletely healed) bone fracture. This includes history of abdominal fistula, tracheoesophageal fistula, gastrointestinal perforation, or intra-abdominal abscess for which an interval of 6 months must pass before study entry. In addition, the participant must have undergone correction (or spontaneous healing) of the perforation/fistula and/or the underlying process causing the fistula/perforation. * Have a significant risk of hemorrhage (per investigator clinical judgment) as defined in the protocol. * Have superior vena cava syndrome or symptoms of spinal cord compression that requires urgent medical intervention. NOTE: Other protocol defined Inclusion/Exclusion criteria apply.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Extensive-stage small-cell lung cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
188 sites in 13 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
ACRC Arizona Clinical Research Center
RECRUITINGTucson, Arizona, 85715, United States
-
Acibadem Adana Hospital
WITHDRAWNAdana, 1130, Turkey (Türkiye)
-
Addenbrooke's Hospital - Cambridge University Hospitals NHS Foundation Trust
RECRUITINGCambridge, CB2 0QQ, United Kingdom
-
Affiliated Hospital of Hebei University
ACTIVE_NOT_RECRUITINGBaoding, 071105, China
-
Ageo Central General Hospital
RECRUITINGAgeo, 362-8588, Japan
-
Ajou University Hospital
RECRUITINGSuwon, Gyeonggi-do, 16499, South Korea
-
Akdeniz University Hospital
RECRUITINGAntalya, Turkey (Türkiye)
-
Anhui Provincial Hospital
ACTIVE_NOT_RECRUITINGHefei, 230001, China
-
Ankara Bilkent City Hospital
RECRUITINGAnkara, 6800, Turkey (Türkiye)
-
Ankara Etlik City Hospital
RECRUITINGAnkara, 06170, Turkey (Türkiye)
-
Ankara University Medical Faculty Hospital
RECRUITINGMamak, 06220, Turkey (Türkiye)
-
Asan Medical Center (AMC)
RECRUITINGSeoul, 5505, South Korea
-
Asklepios Fachkliniken Muenchen Gauting
RECRUITINGGauting, 82131, Germany
-
Azienda Ospedaliera San Giuseppe Moscati
RECRUITINGAvellino, 83100, Italy
-
Azienda Socio Sanitaria Territoriale di Cremona
RECRUITINGCremona, 26100, Italy
-
Baptist Cancer Center
RECRUITINGSouthaven, Mississippi, 38671, United States
-
Baptist Health Hardin Cancer Center
RECRUITINGElizabethtown, Kentucky, 42701, United States
-
Baskent University Adana Turgut Noyan Application and Research Center
RECRUITINGAdana, 1250, Turkey (Türkiye)
-
Beijing Chest Hospital,Capital Medical University
ACTIVE_NOT_RECRUITINGBeijing, 101149, China
-
Beijing Friendship Hospital, Capital Medical University
ACTIVE_NOT_RECRUITINGBeijing, 100050, China
-
Beth Israel Lahey Health - Lahey Hospital & Medical Center (LHMC), Lahey Clinic Medical Center
RECRUITINGBurlington, Massachusetts, 01805, United States
-
CHU de Caen
RECRUITINGCaen, 14033, France
-
CHU de Rennes, Hopital de Pontchaillou
RECRUITINGRennes, 35033, France
-
Cairns Hospital
RECRUITINGCairns, Queensland, 4870, Australia
-
Cairns Hospital
RECRUITINGCairns, 4870, Australia
-
Calvary Mater Newcastle
RECRUITINGWaratah, New South Wales, 2298, Australia
-
Cancer Care Centers of Brevard, Inc
RECRUITINGPalm Bay, Florida, 32901, United States
-
Cancer Care Wollongong Pty Limited
RECRUITINGWollongong, New South Wales, 2500, Australia
-
Cancer Hospital Chinese Academy of Medical Sciences
ACTIVE_NOT_RECRUITINGHebei, 065001, China
-
Cancer Hospital of Shantou University Medical College
WITHDRAWNShantou, 515041, China
-
Cardiomed
RECRUITINGCluj-Napoca, 400015, Romania
-
Casa Di Cura Polispecialistica Dott Pederzoli
RECRUITINGPeschiera del Garda, 37019, Italy
-
Centre Hospitalier Intercommunal Toulon La Seyne Sur Mer (C.H.I.T.S) - Hopital Sainte Musse
RECRUITINGToulon, 83056, France
-
Centre Hospitalier Universitaire d'Angers (CHU Angers)
RECRUITINGAngers, 49933, France
-
Centro di Riferimento Oncologico
RECRUITINGAviano, 33081, Italy
-
Centrul de Oncologie Euroclinic srl
RECRUITINGIași, 700106, Romania
-
Centrul de Oncologie Sf. Nectarie S.R.L (Sf Nectarie Oncology Center)
RECRUITINGCraiova, 200542, Romania
-
Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK)
RECRUITINGBerlin, 13353, Germany
-
Chongqing University Three Gorges Hospital
ACTIVE_NOT_RECRUITINGWanzhou, 404000, China
-
Chungbuk National University Hospital
RECRUITINGCheongju-si, 28644, South Korea
-
Churchill Hospital - Oxford University Hospitals NHS Foundation Trust
RECRUITINGOxford, Oxfordshire, OX3 7LE, United Kingdom
-
City Hospital Onesti
RECRUITINGOnești, 601048, Romania
-
Clermont Oncology Center
TERMINATEDClermont, Florida, 34711, United States
-
Cleveland Clinic - Akron General Hematology & Oncology
RECRUITINGAkron, Ohio, 44302, United States
-
Cleveland Clinic - Hillcrest Hospital
RECRUITINGMayfield Heights, Ohio, 44124, United States
-
Cleveland Clinic Foundation
RECRUITINGCleveland, Ohio, 44195-0001, United States
-
Cleveland Clinic Mercy Hospital Cancer Center
RECRUITINGCanton, Ohio, 44708, United States
-
Clinica MD Anderson International
RECRUITINGMadrid, 28033, Spain
-
Coltea Clinical Hospital
RECRUITINGBucharest, 030171, Romania
-
Consorcio Hospitalario Provincial de Castellon
RECRUITINGCastellon, 12002, Spain
-
Cornell University - NewYork-Presbyterian/Weill Cornell Medical Center
RECRUITINGNew York, New York, 10065, United States
-
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
RECRUITINGAnkara, 6200, Turkey (Türkiye)
-
Evangelische Lungenklinik Berlin
RECRUITINGBerlin, 13125, Germany
-
Fort Wayne Medical Oncology and Hematology, Inc
RECRUITINGFort Wayne, Indiana, 46804, United States
-
Frederick Health Hospital- James M Stockman Cancer Institute
RECRUITINGFrederick, Maryland, 21704, United States
-
Fudan University - Shanghai Cancer Center (FUSCC)
ACTIVE_NOT_RECRUITINGShanghai, 200032, China
-
Fujian Provincial Cancer Hospital
ACTIVE_NOT_RECRUITINGFuzhou, 350014, China
-
FutureMeds Krakow
RECRUITINGKrakow, 31-501, Poland
-
Gachon University Gil Medical Center
RECRUITINGIncheon, Namdong-gu, 21565, South Korea
-
Gazi University, Medical Faculty Hospital
RECRUITINGAnkara, 6560, Turkey (Türkiye)
-
Goztepe Prof. Dr. Suleyman Yalcin City Hospital
RECRUITINGIstanbul, 41380, Turkey (Türkiye)
-
Guangdong General Hospital
ACTIVE_NOT_RECRUITINGGuangzhou, 510080, China
-
Guangxi Tumour Hospital
ACTIVE_NOT_RECRUITINGNanning, 530000, China
-
Gulhane Training and Research Hospital
RECRUITINGAnkara, 6010, Turkey (Türkiye)
-
Guy's Hospital - Guy's & St Thomas' NHS Foundation Trust
RECRUITINGLondon, SE1 9RT, United Kingdom
-
Gyeongsang National University Hospital (GNUH)
RECRUITINGJinju, Gyeongsangnam-do, 52727, South Korea
-
Hacettepe University Medical Faculty Hospital
RECRUITINGAnkara, 6230, Turkey (Türkiye)
-
Harbin Medical University Cancer Hospital
WITHDRAWNHa’erbin, 150040, China
-
Helen G. Nassif Community Cancer Center
RECRUITINGCedar Rapids, Iowa, 52403, United States
-
Helios Klinikum Wuppertal-Universitaet Witten-Herdecke
RECRUITINGWuppertal, 42283, Germany
-
Hematology Oncology Associates of Fredericksburg, Inc.
RECRUITINGFredericksburg, Virginia, 22408, United States
-
Henan Cancer Hospital (Affiliated Cancer Hospital of Zhengzhou University)
ACTIVE_NOT_RECRUITINGZhengzhou, 450008, China
-
Hospital Alvaro Cunqueiro
RECRUITINGVigo, 36312, Spain
-
Hospital Clinico Universitario Lozano Blesa de Zaragoza
RECRUITINGZaragoza, 50009, Spain
-
Hospital General Universitario Gregorio Maranon (HGUGM)
RECRUITINGMadrid, 28007, Spain
-
Hospital Regional Universitario de Malaga
RECRUITINGMálaga, 29010, Spain
-
Hospital Universitario De Leon
RECRUITINGLeón, 24071, Spain
-
Hospital Universitario Nuestra Senora De Valme
RECRUITINGSeville, 41014, Spain
-
Hospital Universitario Vall d'Hebron
RECRUITINGBarcelona, 08035, Spain
-
Hospital Universitario de Badajoz
RECRUITINGBadajoz, 06006, Spain
-
Hospital Universitario de Torrejón
RECRUITINGTorrejón de Ardoz, 28850, Spain
-
Huddersfield Royal Infirmary - Calderdale and Huddersfield NHS Foundation Trust
RECRUITINGHuddersfield, North Yorkshire, HD3 3EA, United Kingdom
-
Hull University Teaching Hospitals NHS Trust
RECRUITINGCottingham, HU16 5JQ, United Kingdom
-
IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST)
RECRUITINGMeldola, 47014, Italy
-
Icon Cancer Centre Kurralta Park
RECRUITINGKurralta Park, South Australia, 5037, Australia
-
Illinois Cancer Specialists
RECRUITINGNiles, Illinois, 60714, United States
-
Institut Bergonie - Centre Regional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
RECRUITINGBordeaux, 33076, France
-
Institut Curie - Centre de Recherche
RECRUITINGParis, 75005, France
-
Institut de Cancerologie de l'Ouest (ICO)- CRLCC Rene Gauducheau
RECRUITINGSaint-Herblain, 44805, France
-
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti (IOB)
RECRUITINGBucharest, 022328, Romania
-
Jeroen Bosch Ziekenhuis
RECRUITING's-Hertogenbosch, 5223 GZ, Netherlands
-
Jiamusi Cancer Hospital
ACTIVE_NOT_RECRUITINGJiamusi, 154007, China
-
Jiangsu Peoples Hospital
ACTIVE_NOT_RECRUITINGNanjing, 210029, China
-
Jilin Cancer Hospital
ACTIVE_NOT_RECRUITINGChangchun, Jilin, 130012, China
-
KOMED Roman Karaszewski I Wspolnicy Spolka Jawna
RECRUITINGKonin, 62-500, Poland
-
Kanagawa Cancer Center
RECRUITINGYokohama, 241-8515, Japan
-
Katowickie Centrum Onkologii
RECRUITINGKatowice, 40-074, Poland
-
Kettering Medical Center
RECRUITINGKettering, Ohio, 45429, United States
-
Klinikum Chemnitz Gmbh
RECRUITINGChemnitz, 09116, Germany
-
Klinikum Esslingen GmbH
RECRUITINGEsslingen am Neckar, 73730, Germany
-
Klinikum Kempten-Oberallgau gGmbH
RECRUITINGKempten, 87439, Germany
-
Klinikum Nuernberg Nord
RECRUITINGNuremberg, 90419, Germany
-
Kobe City Medical Center General Hospital
RECRUITINGKobe, 650-0047, Japan
-
Koc Universitesi Hastanesi (Koc University Hospital)
RECRUITINGIstanbul, 34010, Turkey (Türkiye)
-
Kocaeli University Medical Faculty Hospital
RECRUITINGKocaeli, 41380, Turkey (Türkiye)
-
Korea University Guro Hospital
RECRUITINGSeoul, Guro-gu, 8308, South Korea
-
Krankenhaus Martha-Maria Halle-Doelau gGmbH
RECRUITINGHalle, 06120, Germany
-
Kurume University Hospital
RECRUITINGKurume, 830-0011, Japan
-
LSU Health Baton Rouge - North Clinic
RECRUITINGBaton Rouge, Louisiana, 70805, United States
-
Linyi Cancer Hospital
ACTIVE_NOT_RECRUITINGLinyi, 276034, China
-
Liv Hospital Ankara
RECRUITINGAnkara, 6680, Turkey (Türkiye)
-
Liverpool Hospital
RECRUITINGSydney, 2170, Australia
-
LungenClinic Grosshansdorf GmbH
RECRUITINGGroßhansdorf, 22927, Germany
-
MVZ for oncology and hematology Rhein-Kreis Neuss GmbH
RECRUITINGNeuss, 41462, Germany
-
Maria Sklodowska Curie National Research Institute of Oncology
RECRUITINGWarsaw, 02-781, Poland
-
Marmara University Pendik Training and Research Hospital
RECRUITINGIstanbul, 34899, Turkey (Türkiye)
-
Matsusaka Municipal Hospital
RECRUITINGMatsusaka, 515-8544, Japan
-
McFarland Clinic
RECRUITINGAmes, Iowa, 50010, United States
-
Medical Park Florya Hospital
RECRUITINGIstanbul, 34295, Turkey (Türkiye)
-
Medical Point Izmir Hospital
RECRUITINGIzmir, 35575, Turkey (Türkiye)
-
Memorial Ankara Hospital
RECRUITINGAnkara, 6520, Turkey (Türkiye)
-
Millennium Research and Clinical Development, LLC
TERMINATEDHouston, Texas, 77090, United States
-
N.Copernicus Memorial Hospital
RECRUITINGLodz, 93-513, Poland
-
NHO Kinki Chuo Chest Medical Center
RECRUITINGSakai, 591-8555, Japan
-
National Cancer Center
RECRUITINGGoyang-si, Gyeonggi-do, 10408, South Korea
-
National Cancer Center Hospital
RECRUITINGChūōku, 104-0045, Japan
-
National Hospital Organization Himeji Medical Center
RECRUITINGHimeji, 670-8520, Japan
-
National Hospital Organization Iwakuni Clinical Center
RECRUITINGIwakuni, 740-8510, Japan
-
National Hospital Organization Kyushu Cancer Center
RECRUITINGFukuoka, 811-1395, Japan
-
National Hospital Organization Nagoya Medical Center
RECRUITINGNagoya, 460-0001, Japan
-
National Hospital Organization Shikoku Cancer Center
RECRUITINGMatsuyama, 791-0280, Japan
-
National Hospital Organization Yamaguchi-Ube Medical Center
RECRUITINGUbe, 755-0241, Japan
-
Nebraska Hematology-Oncology (NHO)
RECRUITINGLincoln, Nebraska, 68506, United States
-
New Cross Hospital
RECRUITINGWolverhampton, West Midlands, WV10 0QP, United Kingdom
-
Niigata Cancer Center Hospital
RECRUITINGNiigata, 951-8566, Japan
-
Ninewells Hospital and Medical School - Tayside Health Board
RECRUITINGDundee, Scotland, DD1 9SY, United Kingdom
-
Northern Centre for Cancer Care - The Newcastle Upon Tyne Hospitals NHS Foundation Trust
RECRUITINGNewcastle upon Tyne, Northumberland, NE7 7DN, United Kingdom
-
Northern Jiangsu Peoples Hospital (NJPH)
WITHDRAWNYangzhou, 225001, China
-
Northside Hospital Atlanta
RECRUITINGAtlanta, Georgia, 30342, United States
-
Nottingham University Hospitals NHS Trust - Nottingham City Hospital
RECRUITINGNottingham, Nottinghamshire, NG5 1PB, United Kingdom
-
Okayama University Hospital
RECRUITINGOkayama, 700-8558, Japan
-
Olivia Newton-John Cancer Wellness & Research centre
RECRUITINGHeidelberg, Victoria, 3084, Australia
-
Oncocenter Oncologie Clinica S.R.L
RECRUITINGTimișoara, 300166, Romania
-
Oncomed
RECRUITINGTimișoara, 300239, Romania
-
Osaka Prefectural Hospital Organization Osaka International Cancer Institute
RECRUITINGOsaka, 541-8567, Japan
-
Ospedale San Luca
RECRUITINGLucca, 55100, Italy
-
Our Lady of the Lake Hospital, Inc.
RECRUITINGBaton Rouge, Louisiana, 70808, United States
-
Parc de Salut Mar - Hospital del Mar
RECRUITINGBarcelona, 08003, Spain
-
Peking Union Medical College Hospital
WITHDRAWNBeijing, 100730, China
-
Peninsula & South Eastern Haematology and Oncology Group
RECRUITINGFrankston, Victoria, 3199, Australia
-
Pratia Onkologia Katowice
RECRUITINGKatowice, 40-519, Poland
-
Pratia S.A. , Pratia Poznan
RECRUITINGPoznan, 60192, Poland
-
Pratia Wroclaw Onkologia
RECRUITINGWroclaw, 50-019, Poland
-
Praxiskooperation Bonn-Euskirchen-Rheinbach-Wesseling
RECRUITINGBonn, 53123, Germany
-
Royal Devon and Exeter Hospital, Royal Devon University Healthcare NHS Foundation Trust
RECRUITINGExeter, EX2 5DW, United Kingdom
-
Royal Marsden Hospital (RMH) - Royal Marsden NHS Foundation Trust
RECRUITINGChelsea, London, SW3 6JJ, United Kingdom
-
Royal Marsden Hospital (Sutton) - Royal Marsden NHS Foundation Trust
RECRUITINGSutton, London, SM2 5PT, United Kingdom
-
Royal North Shore Hospital
RECRUITINGSaint Leonards, 2065, Australia
-
Royal Preston Hospital - Lancashire Teaching Hospitals NHS Foundation Trust
RECRUITINGPreston, PR2 9HT, United Kingdom
-
Royal Stoke University Hospital - University Hospitals of North Midlands NHS Trust
RECRUITINGStoke-on-Trent, Staffordshire, ST4 6QG, United Kingdom
-
SC Oncopremium Team SRL
RECRUITINGBaia Mare, 430291, Romania
-
SRH Wald-Kliniken Gera GmbH
RECRUITINGGera, 07548, Germany
-
Saitama Medical University International Medical Center
RECRUITINGHidaka, 350-1298, Japan
-
Saitama Prefectural Cancer Center
RECRUITINGSaitama, 362-0806, Japan
-
Sakarya University Training and Research Hospital
RECRUITINGSakarya, 54290, Turkey (Türkiye)
-
Samsung Medical Center
RECRUITINGSeoul, 6351, South Korea
-
Sendai Kousei Hospital
RECRUITINGMiyagi, 981-0914, Japan
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, 3722, South Korea
-
Seyhan Medical Park Hospital
RECRUITINGAdana, 1140, Turkey (Türkiye)
-
Shandong Cancer Hospital and Institute
ACTIVE_NOT_RECRUITINGJinan, 250117, China
-
Shandong University - Jinan Central Hospital
ACTIVE_NOT_RECRUITINGJinan, 250013, China
-
Shanghai Chest Hospital
ACTIVE_NOT_RECRUITINGShanghai, 200030, China
-
Shanxi Provincial Tumor Hospital (Shanxi Oncology Hospital)
ACTIVE_NOT_RECRUITINGTaiyuan, 030013, China
-
Shenandoah Oncology
RECRUITINGWinchester, Virginia, 22601, United States
-
Shibukawa Medical Center
RECRUITINGShibukawa, 377-0280, Japan
-
Sir Charles Gairdner Hospital (SCGH)
RECRUITINGNedlands, 6009, Australia
-
St James's University Hospital - Leeds Teaching Hospitals NHS Trust
RECRUITINGLeeds, LS9 7TF, United Kingdom
-
St. Luke's Physician Group - St. Luke's Cancer Care Associates
RECRUITINGFountain Hill, Pennsylvania, 18015-1153, United States
-
Staedtisches Klinikum Muenchen Bogenhausen
RECRUITINGMünchen, 81925, Germany
-
Szpital Wojewodzki im. Mikolaja Kopernika w Koszalinie
RECRUITINGKoszalin, 75-581, Poland
-
Taizhou Hospital of Zhejiang Province
ACTIVE_NOT_RECRUITINGZhejiang, 317000, China
-
Texas Oncology Cancer Center
RECRUITINGSugar Land, Texas, 77479, United States
-
The Catholic University Of Korea, St. Vincent's Hospital
RECRUITINGSuwon, Gyeonggi-do, 16247, South Korea
-
The Christ Hospital Cancer Center
RECRUITINGCincinnati, Ohio, 45219, United States
-
The Christie NHS Foundation Trust
RECRUITINGManchester, Lancashire, M20 4BX, United Kingdom
-
The Cleveland Clinic Cancer Center at Fairview Hospital, Moll Pavilion
RECRUITINGCleveland, Ohio, 44111, United States
-
The First Affiliated Hospital Of Wenzhou Medical University
WITHDRAWNWenzhou, 325000, China
-
The First Affiliated Hospital of Bengbu Medical College
ACTIVE_NOT_RECRUITINGBengbu, 233004, China
-
The First Affiliated Hospital of Henan Medical University
ACTIVE_NOT_RECRUITINGXinxiang, 453100, China
-
The First Affiliated Hospital of Nanchang University
ACTIVE_NOT_RECRUITINGNanchang, 330006, China
-
The First Affiliated Hospital of Soochow University
ACTIVE_NOT_RECRUITINGSuzhou, 215006, China
-
The Queen Elizabeth Hospital
RECRUITINGWoodville, South Australia, 5011, Australia
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Tokyo Metropolitan Komagome Hospital
RECRUITINGBunkyō City, 113-8677, Japan
-
Torbay and South Devon NHS Foundation Trust
RECRUITINGTorquay, South Devon, TQ2 7AA, United Kingdom
-
Trakya University Faculty of Medicine
RECRUITINGEdirne, 22030, Turkey (Türkiye)
-
UOC Oncoematologia AOU Luigi Vanvitelli
RECRUITINGNaples, 80131, Italy
-
UOMI Cancer Center-Clinica Tres Torres
RECRUITINGBarcelona, 08017, Spain
-
Union Hospital Tongji Medical College of Huazhong University of Science and Technology (HUST)
ACTIVE_NOT_RECRUITINGWuhan, 430022, China
-
Universidad de Sevilla - Hospital Universitario Virgen Macarena
RECRUITINGSeville, 41009, Spain
-
Universita Degli Studi Di Milano-Bicocca - Azienda Ospedaliera San Gerardo Di Monza
RECRUITINGMonza, 20900, Italy
-
Universitaetsklinikum Schleswig-Holstein (UKSH) - Campus Luebeck
RECRUITINGLübeck, 23538, Germany
-
Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur)
RECRUITINGValencia, 46026, Spain
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
-
University Medical Center of Johannes Gutenberg-University Mainz
RECRUITINGMainz, 55131, Germany
-
University of Tennessee Medical Center
RECRUITINGKnoxville, Tennessee, 37920, United States
-
Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie
RECRUITINGLublin, 20-090, Poland
-
Uniwersyteckie Centrum Kliniczne
RECRUITINGGdansk, 80-214, Poland
-
Velindre NHS Trust, Velindre Cancer Centre
RECRUITINGCardiff, Wales, CF14 2TL, United Kingdom
-
Virginia Cancer Specialists
RECRUITINGFairfax, Virginia, 22031, United States
-
Virginia Commonwealth University School of Medicine
RECRUITINGRichmond, Virginia, 23298, United States
-
Warminsko Mazurskie Centrum Chorob Pluc w Olsztynie
RECRUITINGOlsztyn, 10-357, Poland
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
-
West Cancer Center & Research Institute
RECRUITINGGermantown, Tennessee, 38138, United States
-
Western Health Sunshine Hospital
RECRUITINGSt Albans, Victoria, 3021, Australia
-
White Plains Hospital
RECRUITINGWhite Plains, New York, 10601, United States
-
Wielkopolskie Centrum Pulmonologii i Tarakochirurgii
RECRUITINGPoznan, 60-569, Poland
-
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu
RECRUITINGPrzemyśl, 37-700, Poland
-
Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy
RECRUITINGWarsaw, 04-349, Poland
-
Xiangyang Central Hospital
ACTIVE_NOT_RECRUITINGXiangyang, 441000, China
-
Yeditepe University Kosuyolu Hospital
RECRUITINGIstanbul, 34718, Turkey (Türkiye)
-
Yokohama Municipal Citizen's Hospital
RECRUITINGYokohama, 221-0855, Japan
-
Yunnan Provincial Cancer Hospital
ACTIVE_NOT_RECRUITINGKunming, 650000, China
-
Zhejiang Medical University, Zhejiang Cancer Hospital
ACTIVE_NOT_RECRUITINGHangzhou, 310022, China
-
Zhongnan Hospital of Wuhan University
ACTIVE_NOT_RECRUITINGWuhan, 430071, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo outperform standard care in aggressive lung cancer?
- Can a targeted drug combo outperform standard care for aggressive lung cancer?
- Can a Two-Drug attack shrink tough lung cancers?
- Can a smartphone app ease the burden of advanced lung cancer?
- Cholesterol-Lowering drug may boost lung cancer immunotherapy
- Lung cancer drug tislelizumab under Real-World scrutiny in 440-Patient european study